Merck KGaA (MKGAF)
(Delayed Data from OTC)
$171.66 USD
-10.89 (-5.97%)
Updated Sep 23, 2024 01:35 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MKGAF 171.66 -10.89(-5.97%)
Will MKGAF be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MKGAF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MKGAF
Here's What Could Help Merck KGaA (MKGAF) Maintain Its Recent Price Strength
Merck KGaA (MKGAF) Upgraded to Buy: Here's What You Should Know
MKGAF: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes Merck KGaA (MKGAF) a Good Fit for 'Trend Investing'
HEXO (HEXO) Reports Q3 Loss, Lags Revenue Estimates
Catalent (CTLT) Reports Q3 Loss, Tops Revenue Estimates
Other News for MKGAF
Recursion: Path Forward For REC-994 Remains Despite Mixed Response
Week In Review: Eisai Enters $1.5 Billion Molecular Glues Pact With SEED
Week In Review: Eisai Enters $1.5 Billion Molecular Glues Pact With SEED
European exporters with stretched valuations - JPM
Merck KGaA (MKGAF) Q2 2024 Earnings Call Transcript